Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population

BACKGROUND: Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder and a leading genetic cause of infant death worldwide. However, there is no routine screening program for SMA in the UK. Lack of treatments and the inability of screening tests to accurately predict disease severity are...

Descripción completa

Detalles Bibliográficos
Autores principales: Boardman, Felicity K., Sadler, Chloe, Young, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823674/
https://www.ncbi.nlm.nih.gov/pubmed/29169204
http://dx.doi.org/10.1002/mgg3.353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823674/
https://www.ncbi.nlm.nih.gov/pubmed/29169204
http://dx.doi.org/10.1002/mgg3.353

Ejemplares similares